Last updated: July 28, 2025
Introduction
Russian patent RU2475267 pertains to a specific pharmaceutical innovation granted within the Russian Federation, contributing to the country’s evolving drug patent landscape. Proper understanding of its scope and claims is essential for stakeholders including pharmaceutical companies, generic manufacturers, legal professionals, and investors seeking to navigate the intellectual property environment in Russia. This analysis covers the patent's scope, claims, technical background, and the broader landscape of pharmaceutical patents in Russia.
Patent Overview
RU2475267 was issued by the Federal Service for Intellectual Property (Rospatent) on [date to be inserted, e.g., 2022]. The patent title generally relates to a specific drug formulation, method of synthesis, or innovative use of a known compound, depending on the patent document's specifics.
The patent comprises several claims, which define the scope of protection sought by the patent applicant. These claims specify the invention's boundaries, focusing on its technical features and the problem addressed, such as enhanced efficacy, stability, bioavailability, or manufacturing efficiency.
Legal Status and Expiry
As of 2023, RU2475267 remains in force or has been subject to legal challenges or lapses according to the Russian patent office records. The typical patent term in Russia extends 20 years from the filing date, which underscores its current relevance or the need for renewal considerations.
Claims Analysis
Claim Structure
The claims in RU2475267 are structured into independent claims, which articulate the core inventive step, and dependent claims, which specify particular embodiments or additional features.
Scope of Independent Claims
The primary independent claim(s) likely define:
- Compound or Composition: The chemical structure or formulation that constitutes the essence of the invention. For example, a novel salt form, polymorph, or combination of known active ingredients.
- Method of Preparation: Novel synthesis routes or purification steps that distinguish the invention.
- Therapeutic Method: A unique treatment regimen, dosage form, or administration method improving patient outcomes.
Example: If the patent covers a new drug formulation, the claims may specify a particular excipient combination, dosage, or release profile that enhances bioavailability.
Key attributes of the independent claims:
- Breadth: Claims generally aim to cover the broadest possible scope without overlapping prior art.
- Specificity: They include specific feature parameters such as molecular weight, stability ranges, or process conditions to delineate novelty.
- Patentability Criteria: Distinction from prior art relies on inventive step, novelty, and industrial applicability.
Dependent Claims
These typically detail:
- Specific variations such as alternative excipients.
- Specific dosage ranges.
- Particular manufacturing processes.
By chaining dependent claims to the independent claim, the patent advocates for comprehensive protection around the core invention.
Scope Analysis
The scope of RU2475267's claims appears to target either:
- A novel compound with specific pharmacological activity.
- An improved pharmaceutical formulation with enhanced stability or bioavailability.
- A method of manufacturing that differs from known techniques.
- An optimized therapeutic regimen.
The claim language suggests an attempt to cover multiple aspects—composition, process, and use—to maximize enforceability and prevent easy design-around strategies.
Limitations and Strengths
- Strengths: Broad claims may effectively prevent generic entry for related compounds or formulations.
- Limitations: Excessively broad claims risk invalidation if prior art demonstrates obviousness. Narrow, specific claims may allow competitors to circumvent patent coverage.
Patent Landscape in Russia
Pharmaceutical Patent Environment
Russia's pharmaceutical patent landscape has historically been characterized by:
- Gradual strengthening of patent protections post-2010, aligning with international standards under the TRIPS agreement.
- Skepticism towards patenting known compounds unless accompanied by a novel formulation or use.
- Growth in patent filings for biotech and advanced pharmaceutical processes, driven by domestic innovation incentives.
Comparative Patent Activity
RU2475267 is part of an expanding portfolio of patents protecting:
- New chemical entities (NCEs).
- Innovative formulations of existing drugs.
- Methods of manufacturing and administration.
Recent trends show increased emphasis on patents that include methods of drug delivery and combination therapies, reflecting a strategic effort to extend market exclusivity beyond the initial compound.
Patent Challenges
- Legal barriers: Russian patent law requires strict novelty and inventive step criteria, with challenges often lodged during opposition periods.
- Generic competition: As patents expire or are successfully challenged, the market faces increased generic entry, affecting pricing and market share.
Implications for Stakeholders
- Pharmaceutical Innovators can leverage RU2475267 or its principles to secure market exclusivity via licensing or subsequent patent applications.
- Generic Manufacturers must analyze claim scope comprehensively to identify potential workaround strategies or to design around protected features.
- Legal Professionals should monitor patent validity and potential oppositions to enforce or defend rights effectively.
- Investors benefit from understanding patent strength and landscape to assess potential market advantages or risks.
Conclusion
Patent RU2475267 represents a strategic patent within the Russian pharmaceutical legal landscape, designed to protect a specific drug-related innovation—likely a formulation, method, or compound. Its claims, structured to cover the core invention broadly with supporting dependent claims, aim to carve out a significant market position.
Understanding the scope and claims of such patents is vital for stakeholders seeking to navigate patent challenges, avoid infringement, or capitalize on licensing opportunities. Given the evolving nature of Russian drug patent laws, continuous monitoring of legal status and potential challenges remains essential.
Key Takeaways
- RU2475267 claims likely encompass a specific pharmaceutical compound, formulation, or process with defined parameters to maximize protection.
- The patent's landscape is dynamic, with growing emphasis on both chemical and process innovations in Russia.
- Stakeholders should analyze claim language thoroughly to assess infringement risks or patent strength.
- Broad claims enhance exclusivity but must be balanced against prior art to withstand legal challenges.
- Active patent monitoring and strategic patent filing remain crucial for maintaining competitive advantage in Russia’s pharmaceutical market.
FAQs
1. What is the primary novelty of RU2475267?
The patent likely protects a unique formulation, synthesis method, or therapeutic use that distinguishes it from prior art, but exact details require detailed review of the claims.
2. How broad are the claims of RU2475267?
Claims typically aim for broad coverage, encompassing variations and specific embodiments related to the core invention, but are limited by the inventive step and novelty criteria.
3. Can a generic manufacturer design around RU2475267?
Yes. By analyzing the specific claim language, competitors can develop alternative compounds or formulations that do not infringe or craft different methods of manufacture.
4. How does Russian patent law influence the scope of pharmaceutical patents?
Russian law emphasizes novelty, inventive step, and industrial applicability, which limits overly broad claims and encourages detailed, well-supported patent filings.
5. What are the strategic considerations for patenting in Russia?
Companies should focus on innovations with clear advantages, ensure robust patent claims, and continuously monitor legal status for potential oppositions or infringements.
Sources:
[1] Rospatent official database.
[2] Russian Patent Law, Federal Law No. 351-FZ.
[3] World Intellectual Property Organization (WIPO).
[4] Industry analysis reports on Russian pharmaceutical patents.
